Analyst Price Target is $5.00
▲ +214.47% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Nephros in the last 3 months. The average price target is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 214.47% upside from the last price of $1.59.
Current Consensus is
Buy
The current consensus among 1 polled investment analysts is to buy stock in Nephros. This rating has held steady since April 2023, when it changed from a Hold consensus rating.
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Read More
